Pediatric Primary Care Case Studies (144 page)

gross motor delays (infants),
11
–18

language/social delays (toddlers),
28
–31

of diseases

acne (adolescents),
468
–469

AD,
456
–457

anemia (toddlers),
296

cough,
378
–380

diarrhea/vomiting,
388
–395

fever,
234
–239

headache,
322
–324

late-preterm infants (well-child care),
494
–496

oral trauma,
407
–411

overweight/high blood sugar,
269
–275

recurrent ear infections (toddlers),
348
–350

red eye (preschoolers),
336

syncope,
360
–361,
361
t

urinary urgency/incontinence (preschoolers),
418
–419

vaginal discharge (adolescents),
446

wheezing,
252
–259

of functional/mental health problems

abuse situations,
193
–195

constipation (school-age children),
116
–117,
117
–118

depression (adolescents),
208
–211

overweight (preschoolers),
88
–90

sleep patterns (infants),
163
–166

epinastine HCl (Elestat),
343
t

EPR-3 (Expert Panel Report 3) guidelines,
259
–260

Epstein-Barr virus.
See
EBV (Epstein-Barr virus)

ERIC (Epidemiology of Diabetes Interventions and Complications),
274

erythromycin,
353
–354,
353
t,
383
–384,
472
–473,
475
t–477t

erythromycin/sulfisoxazole (Pediazole),
356
t

Escherichia coli
,
388
,
418
,
420

escitalopram (Lexapro),
217
t

estrogen/progesterone,
430
–431,
431
t

etiology.
See
epidemiology/etiology

Eucerin soap,
460

evidenced-based care case studies

for developmental problems,
9
–72

fatigue (adolescents),
59
–72

gross motor delays (infants),
11
–26

language/social delays (toddlers),
27
–42

school failure/refusal problems,
43
–58

diagnostic reasoning for,
1
–8

for diseases,
232
–518

acne (adolescents),
467
–480

anemia (toddlers),
291
–320

birth control (adolescents),
427
–440

cough,
377
–386

fever,
233
–250

headache,
321
–335

high blood sugar/overweight,
267
–290

itchy rash,
455
–466

limp,
481
–492

oral trauma,
405
–416

recurrent ear infections (toddlers),
347
–358

red eye (preschoolers),
335
–346

short stature,
507
–518

syncope,
359
–376

urinary urgency/incontinence (preschoolers),
417
–426

vaginal discharge (adolescents),
441
–454

vomiting/diarrhea,
387
–404

well-child care (late-preterm infants),
493
–506

wheezing,
251
–266

for functional/mental health problems,
73
–230

abuse situations,
193
–206

ADHD,
175
–192,
175
–193

breastfeeding/slow weight gain,
103
–114

constipation (school-age children),
115
–132

depression (adolescents),
207
–220

LGBT issues (adolescents),
221
–231

overweight (preschoolers),
85
–102

PPEs (adolescents),
133
–163

sleep patterns (infants),
163
–175

well-child care (infants),
75
–84

Expert Panel Report 3 guidelines.
See
EPR-3 (Expert Panel Report 3) guidelines

F

FACES pain tool,
481
–482

family-centered care,
4

fatigue (adolescents),
59
–72

case presentation for,
59
,
62
–63,
67
,
69
–70

cultural influences on,
60
–61

development factors of,
61

diagnosis of,
64
–66,
65
t

24-hour diet recall,
62
,
63
t

differential,
64
–66

fatigue as symptom,
59
–60

history-taking,
61
–64,
63
t

laboratory tests,
64
–65,
65
t

epidemiology/etiology of,
60
–61

fundamental contexts of,
59
,
71

management of,
66
–69

follow-up visits,
69
–70

medications,
68

patient education,
68
–69

sleep hygiene measures,
67
,
70
t

therapeutic management plans,
67
–69

objectives for,
59

prognosis for,
69
–70

resources for,
71
–72

female athlete triad,
143
–144,
157